Skip to content
SearchContact UsDirectionsHome
Whitehead Institute for Biomedical Research
About WhiteheadFaculty and ResearchResearch NewsPublic ProgramsCareer OpportunitiesSupport Whitehead
Research News
Search News Archives

On Topic

Paradigm Magazine

Discovery Newsletter

Fact Sheets

Video Gallery

Podcast

For the News Media

whitehead home > research news > search news archives > 2003 news stories > potential new source for adult stem cells

Study Identifies Potential New Source for Adult Stem Cells

CAMBRIDGE, Mass. (Nov. 13, 2003) — Blood stem cells hold great promise for treating inherited blood disorders and certain autoimmune diseases. They also are key in making bone marrow transplantation safer and more successful for patients. But because these cells are so rare, researchers have a difficult time harvesting them from donors. In research reported in the online version of the journal Blood, Whitehead scientists Harvey Lodish and Cheng Cheng Zhang report the discovery of a new blood stem cell growth factor, IGF-2, to add to the short list of known growth factors – that is, proteins that affect cell growth, or in this case, stem cell growth. This discovery provides a new tool that allows researchers to multiply blood stem cells in culture for potential therapeutic use.

Whitehead Institute for Biomedical Research is a nonprofit, independent research and educational institution. Wholly independent in its governance, finances and research programs, Whitehead shares a close affiliation with the Massachusetts Institute of Technology through its faculty, who hold joint MIT appointments.


CONTACT

Communications and Public Affairs
Phone: 617-258-5183
Email: newsroom@wi.mit.edu

Whitehead Institute contact information